Self-reported PTSD is associated with increased use of MDMA in adolescents with substance use disorders
L. Basedow, Sören Kuitunen-Paul, M. Wiedmann, V. Roessner, Y. Golub
European Journal of Psychotraumatology January 1, 2021 DOI: 10.1080/20008198.2021.1968140 via Semantic Scholar
Summary
Adolescents with both a substance use disorder and probable post-traumatic stress disorder report more frequent use of MDMA (ecstasy) than those without PTSD, and they start using substances at a younger age. PTSD symptoms, especially avoidance, appear before first MDMA use, which begins on average 2.2 years after PTSD onset. The association between MDMA use and avoidance symptoms may reflect an attempt to reduce those symptoms or a consequence of regular MDMA use.
Study at a glance
| Characteristics | Observational cohort Peer reviewed |
|---|---|
| Sample size | 121 |
| Population | German adolescent patients with a substance use disorder |
| Keywords | Medicine Psychology |
| Citations | 15 |
| Key finding | Adolescents with co-occurring probable PTSD and substance use disorder report higher frequency of MDMA use and younger age of first substance use than those without PTSD. |
Abstract
ABSTRACT Background: Adolescent patients with a substance use disorder (SUD) often fulfil the criteria for a co-occurring post-traumatic stress disorder (PTSD). However, it is not clear if these dual-diagnosed adolescents present with unique levels of substance use and how their substance use relates to PTSD symptom clusters. Objective: To investigate substance use in adolescents with co-occurring PTSD and SUD. Additionally, we explored how the use of specific substances is related to specific PTSD symptom clusters. Method: We recruited n = 121 German adolescent SUD patients, in three groups: no history of traumatic events (TEs) (n = 35), TEs but not PTSD (n = 48), probable PTSD (n = 38). All groups were administered a trauma questionnaire and were asked to report their past-month substance use. Results: Adolescents with probable PTSD and SUD report a higher frequency of MDMA use than adolescents with no PTSD and no TE (PTSD vs. noTE: U = 510.5, p = .016; PTSD vs. TE: U = 710.0, p = .010). The use of MDMA was more frequent in adolescents with avoidance symptoms (X2 (1) = 6.0, p = .014). Participants report using substances at a younger age (PTSD vs. noTE: U = 372.0, p = .001; PTSD vs. TE: U = 653.5, p = .022) and PTSD symptom onset was on average 2.2 years earlier than first MDMA use (t (26) = −2.89, p = .008). Conclusions: Adolescent SUD patients with probable PTSD are more likely to use MDMA than SUD patients without PTSD. The use of MDMA was associated with reported avoidance symptoms. The first age of MDMA use is initiated after PTSD onset. It is unclear whether the association of MDMA use with avoidance symptoms is due to efforts to reduce these symptoms or a result of regular MDMA use. HIGHLIGHTS We investigated substance use in adolescents with substance use disorders. We observed increased MDMA use and a younger age of first substance use in participants with additional PTSD. Additionally, MDMA use was associated with the presence of specific PTSD symptoms.